Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an antiepileptic presented as an oral tablet for oral use. It is prescribed to control various seizure types in patients with epilepsy, reducing neuronal excitability and seizure frequency and improve quality of life. As part of a comprehensive treatment plan.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Levetiracetam is used in epilepsy management to reduce seizure activity across several seizure types. - Partial‑onset seizures: reduces seizure frequency and improves control in patients with focal epilepsy. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes and lowers risk of injury in generalized epilepsy. - Myoclonic seizures: decreases myoclonic jerks and improves daily functioning in patients with juvenile myoclonic epilepsy. - Adjunct therapy: can be combined with other antiepileptic drugs to enhance overall seizure control.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Dizziness - Fatigue - Headache - Nausea Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, angioedema) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure patient safety. - Renal function: adjust dose in patients with impaired renal clearance. - Pregnancy: risk category unknown; use only if benefits outweigh potential risks. - Psychiatric effects: monitor for mood changes, irritability, or depression. - Concomitant CNS depressants: may increase sedation when combined. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting its efficacy or safety. Major Interactions (Avoid): - Carbamazepine: may significantly reduce levetiracetam plasma concentrations. - Phenytoin: can lower levetiracetam levels, reducing seizure control. - Phenobarbital: may decrease levetiracetam exposure, compromising effectiveness. Moderate Interactions (Monitor Closely): - Alcohol: combined use may enhance central nervous system depression. - Other antiepileptic drugs: may require dose adjustments based on therapeutic response. - Renal excretion inhibitors (e.g., probenecid): may increase levetiracetam levels, necessitating monitoring.